Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
World Journal of Surgery
Erschienen in:

05.01.2022 | Original Scientific Report

Identification of Preoperative Fat-Free Mass Index for the Prognosis of Curatively Resected Esophageal Cancer

verfasst von: Akikazu Yago, Yu Ohkura, Masaki Ueno, Kentoku Fujisawa, Yusuke Ogawa, Hayato Shimoyama, Masayuki Urabe, Shusuke Haruta, Harushi Udagawa

Erschienen in: World Journal of Surgery | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

The progressive, systemic depletion of muscle mass is a poor prognostic factor for various types of cancers. However, the assessment of body composition for patients with esophagectomy remains unclear. Therefore, we evaluated the significance of the fat-free mass index (FFMI) and estimated the appropriate cutoff value.

Methods

We compiled clinicopathological characteristics of patients who underwent curative operation for esophageal cancer between October 2013 and March 2018 at Toranomon Hospital and reviewed them until December 2020. We analyzed the short- and long-term outcomes, compared to conventional nutritional factors, and calculated the area under the receiver operating characteristic (ROC) curve.

Results

A total of 200 patients were eligible for inclusion. FFMI was ineffective in predicting postoperative complications, with no correlation with other nutritional biomarkers. Preoperative low FFMI led to poor overall survival (OS), and the lower cutoff values based on the time-dependent ROC analysis were 14.4 and 16.8 kg/m2 in women and men, respectively. Multivariate analysis for OS revealed that low FFMI (p = 0.010, HR 2.437, 95% CI 1.234–4.815) and clinical stage (p = 0.010, HR 4.781, 95% CI 1.447–15.796) were independent prognostic factors. The 3-year survival rates were 68.9% in low FFMI and 88.6% in normal FFMI.

Conclusions

The low FFMI was not predictive of postoperative complications but an independent prognostic factor in esophageal cancer with curative resection, having no correlation with other biomarkers. Our cutoff FFMI values could be useful in selecting the target for muscle improvement programs.
Literatur
1.
Dodson S, Baracos VE, Jatoi A et al (2011) Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med 62:265–279CrossRef
2.
Tamandl D, Paireder M, Asari R, Baltzer PA, Schoppmann SF, Ba-Ssalamah A (2016) Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol 26:1359–1367CrossRef
3.
Miyamoto Y, Baba Y, Sakamoto Y et al (2015) Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol 22:2663–2668CrossRef
4.
Cederholm T, Jensen GL, Correia MITD et al (2019) GLIM criteria for the diagnosis of malnutrition – a consensus report from the global clinical nutrition community. Clin Nutr 38:1–9CrossRef
5.
Cederholm T, Bosaeus I, Barazzoni R et al (2015) Diagnostic criteria for malnutrition - an ESPEN consensus statement. Clin Nutr 34:335–340CrossRef
6.
Roubenoff R, Baumgartner RN, Harris TB et al (1997) Application of bioelectrical impedance analysis to elderly populations. J Gerontol - Ser A Biol Sci Med Sci 52(3):M129–M136CrossRef
7.
Sergi G, De Rui M, Stubbs B, Veronese N, Manzato E (2017) Measurement of lean body mass using bioelectrical impedance analysis: a consideration of the pros and cons. Aging Clin Exp Res 29:591–597CrossRef
8.
Matsubara H, President F, Ando N et al (2017) Japanese classification of esophageal cancer, 11th edition: part I. Esophagus 14:1–36CrossRef
9.
Kitagawa Y, Uno T, Oyama T et al (2019) Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 1. Esophagus 16:1–24CrossRef
10.
Akiyama H, Miyazono H, Tsurumaru M et al (1978) Use of the stomach as an esophageal substitute. Ann Surg 188:606–610CrossRef
11.
Udagawa H, Akiyama H (2001) Surgical treatment of esophageal cancer: Tokyo experience of the three-field technique. Dis Esophagus 14:110–114CrossRef
12.
Udagawa H, Ueno M, Kinoshita Y (2009) Rationale for video-assisted radical esophagectomy. Gen Thorac Cardiovasc Surg 57:127–131CrossRef
13.
Udagawa H, Ueno M, Shinohara H et al (2012) The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer. J Surg Oncol 106(6):742–747CrossRef
14.
Udagawa H, Ueno M, Shinohara H et al (2014) Should lymph nodes along the thoracic duct be dissected routinely in radical esophagectomy? Esophagus 11:204–210CrossRef
15.
Xue Y, Zhou X, Xue L, Zhou R, Luo J (2019) The role of pretreatment prognostic nutritional index in esophageal cancer: a meta-analysis. J Cell Physiol 234:19655–19662CrossRef
16.
Kinoshita A, Onoda H, Imai N et al (2012) Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer 107:988–993CrossRef
17.
Ignacio De Ulíbarri J, González-Madroño A, De Villar NGP et al (2005) CONUT A tool for controlling nutritional status first validation in a hospital population. Nutr Hosp 20:38–45PubMed
18.
Kuroda D, Sawayama H, Kurashige J et al (2018) Controlling nutritional status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection. Gastric Cancer 21:204–212CrossRef
19.
Lee DH, Keum N, Hu FB et al (2017) Development and validation of anthropometric prediction equations for lean body mass, fat mass and percent fat in adults using the National Health and Nutrition Examination Survey (NHANES) 1999–2006. Br J Nutr 118:858–866CrossRef
20.
Heagerty PJ, Lumley T, Pepe MS (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56:337–344CrossRef
21.
Kudou K, Saeki H, Nakashima Y et al (2019) Postoperative development of sarcopenia is a strong predictor of a poor prognosis in patients with adenocarcinoma of the esophagogastric junction and upper gastric cancer. Am J Surg 217:757–763CrossRef
22.
Harada K, Ida S, Baba Y et al (2016) Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma. Dis Esophagus 29:627–633CrossRef
23.
Ida S, Watanabe M, Yoshida N et al (2015) Sarcopenia is a predictor of postoperative respiratory complications in patients with esophageal cancer. Ann Surg Oncol 22:4432–4437CrossRef
24.
Prado CMM, Lieff JR, Mccargar LJ et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629–635CrossRef
25.
26.
Aoyama T, Kawabe T, Fujikawa H et al (2015) Loss of lean body mass as an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer. Ann Surg Oncol 22:2560–2566CrossRef
27.
Nakashima Y, Saeki H, Nakanishi R et al (2018) Assessment of sarcopenia as a predictor of poor outcomes after esophagectomy in elderly patients with esophageal cancer. Ann Surg 267:1100–1104CrossRef
28.
Muscaritoli M, Anker SD, Argiles J et al (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics.” Clin Nutr 29:154–159CrossRef
29.
Tan LJ, Liu SL, Lei SF et al (2012) Molecular genetic studies of gene identification for sarcopenia. Hum Genet 131:1–31CrossRef
30.
Prado CMM, Baracos VE, McCargar LJ et al (2007) Body composition as an independent determinant of 5-fluorouracil based chemotherapy toxicity. Clin Cancer Res 13:3264–3268CrossRef
31.
Schutz Y, Kyle UUG, Pichard C (2002) Fat-free mass index and fat mass index percentiles in Caucasians aged 18–98 y. Int J Obes Relat Metab Disord 26:953–960CrossRef
32.
Kyle UG, Schutz Y, Dupertuis YM, Pichard C (2003) Body composition interpretation: contributions of the fat-free mass index and the body fat mass index. Nutrition 19:597–604CrossRef
33.
Beck FK, Rosenthal TC, York N (2002) Prealbumin: a marker for nutritional evaluation. Am Fam Phys 65:1575–1578
34.
Bharadwaj S, Ginoya S, Tandon P et al (2016) Malnutrition: laboratory markers vs nutritional assessment. Gastroenterol Rep 4:272–280
35.
Rossi AP, D’Introno A, Rubele S et al (2017) The Potential of β-Hydroxy-β-methylbutyrate as a new strategy for the management of sarcopenia and sarcopenic obesity. Drugs Aging 34:833–840CrossRef
36.
Koyama Y, Moro K, Nakano M et al (2017) Intravenous carnitine administration in addition to parenteral nutrition with lipid emulsion may decrease the inflammatory reaction in postoperative surgical patients. J Clin Med Res 9:831–837CrossRef
37.
Ohara M, Ogawa K, Suda G et al (2018) L-carnitine suppresses loss of skeletal muscle mass in patients with liver cirrhosis. Hepatol Commun 2:910–922CrossRef
38.
Tamaki M, Miyashita K, Hagiwara A et al (2017) Ghrelin treatment improves physical decline in sarcopenia model mice through muscular enhancement and mitochondrial activation. Endocr J 64:S47–S51CrossRef
39.
Yanagita I, Fujihara Y, Kitajima Y et al (2019) A high serum cortisol/DHEA-S ratio is a risk factor for sarcopenia in elderly diabetic patients. J Endocr Soc 3:801–813CrossRef
40.
Yamamoto K, Nagatsuma Y, Fukuda Y et al (2017) Effectiveness of a preoperative exercise and nutritional support program for elderly sarcopenic patients with gastric cancer. Gastric Cancer 20:913–918CrossRef
Metadaten
Titel
Identification of Preoperative Fat-Free Mass Index for the Prognosis of Curatively Resected Esophageal Cancer
verfasst von
Akikazu Yago
Yu Ohkura
Masaki Ueno
Kentoku Fujisawa
Yusuke Ogawa
Hayato Shimoyama
Masayuki Urabe
Shusuke Haruta
Harushi Udagawa
Publikationsdatum
05.01.2022
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 4/2022
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-021-06435-3

Weitere Artikel der Ausgabe 4/2022

Roux-en-Y Versus One Anastomosis Gastric Bypass as Redo-Operations Following Sleeve Gastrectomy: A Retrospective Study

  • Original Scientific Report

Gastric Pneumatosis with Portal Venous Gas can be Treated Non-operatively: A Retrospective Multi-institutional Study

  • Original Scientific Report

Letter to the Editor: ‘Cost–Benefit Analysis of an Enhanced Recovery Program for Gastrectomy a Retrospective Controlled Analysis’

  • Letter to the Editor

Clinical Utility and Characteristics of the LARS Score Compared to the CCIS

  • Original Scientific Report

Augmented Reality-Based Visual Cue for Guiding Central Catheter Insertion in Pediatric Oncologic Patients

  • Original Scientific Report

Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients

  • Open Access
  • Original Scientific Report

Neu im Fachgebiet Chirurgie

Verbände und Cremes gegen Dekubitus: „Wir wissen nicht, was sie bringen!“

Die Datenlage zur Wirksamkeit von Verbänden oder topischen Mitteln zur Prävention von Druckgeschwüren sei schlecht, so die Verfasser einer aktuellen Cochrane-Studie. Letztlich bleibe es unsicher, ob solche Maßnahmen den Betroffenen nutzen oder schaden.

Nackenschmerzen nach Bandscheibenvorfall: Muskeltraining hilft!

Bei hartnäckigen Schmerzen aufgrund einer zervikalen Radikulopathie schlägt ein Team der Universität Istanbul vor, lokale Steroidinjektionen mit einem speziellen Trainingsprogramm zur Stabilisierung der Nackenmuskulatur zu kombinieren.

US-Team empfiehlt Gastropexie nach Hiatushernien-Op.

Zur Vermeidung von Rezidiven nach Reparatur einer paraösophagealen Hiatushernie sollte einem US-Team zufolge der Magen bei der Op. routinemäßig an der Bauchwand fixiert werden. Das Ergebnis einer randomisierten Studie scheint dafür zu sprechen.

Mit Lidocain kommt der Darm nicht schneller in Schwung

Verzögertes Wiederanspringen der Darmfunktion ist ein Hauptfaktor dafür, wenn Patientinnen und Patienten nach einer Kolonresektion länger als geplant im Krankenhaus bleiben müssen. Ob man diesem Problem mit Lidocain vorbeugen kann, war Thema einer Studie.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise